2012 ACR/ARHP Annual Meeting Archives - Page 2 of 180

Abstract Number: 410

Early Growth Response-1 (EGR-1) Controls Synoviocyte Apoptosis, and Its Expression Is Regulated by the Direct Binding of Fibroblast Growth Factor-1 (FGF1) or Insulin-Like Growth Factor-1 (IGF1) to Integrin αvβ3
Abstract Number: 1343

EARLY Improvements in the Lower Limbs Enthesis by Ultrasound Predicting Later Favorable Responses in TNF Inhibotors-Treated Patients with Spondyloarthritis
Abstract Number: 1620

Early Magnetic Resonance Imaging Measures Independently Predict 1- and 2- Year X-Ray Progression: Results From a Large Clinical Trial
Abstract Number: 411

Early Menopause, Smoking and Circulating Antibodies Against Citrullinated Peptides in the Pre-Clinical Phase of Rheumatoid Arthritis
Abstract Number: 1302

Early Neutropenia Is Associated with Clinical Response in Patients Receiving Tocilizumab in Rheumatoid Arthritis
Abstract Number: 2144

Early RA Patients Fulfilling the New 2010 ACR/EULAR Criteria, Display Better Clinical Responses to DMARD Therapy but Have Higher Radiographic Damage Progression Than Patients with Early RA Not Fulfilling the 2010 ACR/EULAR Criteria
Abstract Number: 1691

Early Signs of Subclinical Inflammation and Local Antibody Production in Early Rheumatoid Lungs
Abstract Number: 1836

Early Versus Delayed Initiation of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
Abstract Number: 1479

Early Versus Late Onset Systemic Sclerosis: Analysis of 1037 Patients From Rescle Registry
Abstract Number: 506

Ebv-Mir-Bart13 Affects the Expression of AQP5 in Human Salivary Gland Cell Lines Contributing to the Pathogenesis of Sjögren’s Syndrome
Abstract Number: 933

Economic Burden of Systemic Lupus Erythematosus by Flare Severity in a Commercially Insured Population in the United States
Abstract Number: 1973

Effect of Adalimumab On the Serum Level of Undercarboxylated Osteocalcin (ucOC), Bone Biochemical Markers and Bone Mineral Density
Abstract Number: 261

Effect of Advancing Age On the Gastrointestinal Safety of Celecoxib Versus Nonselective Nonsteroidal Anti-Inflammatory Drugs: A Post Hoc Analysis of GI-Reasons
Abstract Number: 1080

Effect of Anti-NKG2A Antibody Treatment On NK Cell Receptor Expression in Rheumatoid Arthritis Patients
Abstract Number: 756

Effect of B Cell Depletion Therapy with Rituximab On Myositis Associated Autoantibody Levels in Idiopathic Inflammatory Myopathy
Abstract Number: 1705

Effect of Certolizumab Pegol On Inflammation of Spine and Sacroiliac Joints in Patients with Axial Spondyloarthritis: 12 Week Magnetic Resonance Imaging results of a Phase 3 Double Blind Randomized Placebo-Controlled Study
Abstract Number: 2613

Effect of Certolizumab Pegol On Signs and Symptoms in Patients with Psoriatic Arthritis with and without Prior Anti-TNF Exposure: 24 Week Results of a Phase 3 Double-Blind Randomized Placebo-Controlled Study
Abstract Number: 777

Effect of Certolizumab Pegol On Signs and Symptoms of Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis: 24 Week Results of a Double Blind Randomized Placebo-Controlled Phase 3 Axial Spondyloarthritis Study
Abstract Number: 557

Effect of Certolizumab Pegol On the Multiple Facets of Psoriatic Arthritis As Reported by Patients: 24 Week Patient Reported Outcome Results of a Phase 3 Double Blind Randomized Placebo-Controlled Study
Abstract Number: 187

Effect of Colchicine On Cholesterol Levels in Patients with Familial Mediterranean Fever and Behçet’s Syndrome
Abstract Number: 2052

Effect of Community Characteristics On Quality of Care in Systemic Lupus Erythematosus
Abstract Number: 1092

Effect of FULL Contact FOOT Orthosis On Plantar Fasciitis
Abstract Number: 1210

Effect of HLA-DRB1*0901 Suggest Distinctive Mechanisms of Rheumatoid Arthritis Susceptibility
Abstract Number: 1733

Effect of Hydroxychloroquine (HCQ) On the Annexin A5 Resistance Assay (AnxA5-RA) in Antiphospholipid Antibody (aPL)-Positive Patients: Preliminary Results of an Ongoing Prospective Study
Abstract Number: 1946

Effect of Immunosuppressive Treatment On Gene Expression in Patients with Polymyositis and Dermatomyositis
Abstract Number: 493

Effect of Infliximab On Employment Status in Patients with Rheumatoid Arthritis or Ankylosing Spondylitis
Abstract Number: 1233

Effect of Insoles On the Rheumatoid Foot
Abstract Number: 976

Effect of Interactions Between Validated Rheumatoid Arthritis Genetic Factors and Environmental Factors On Rheumatoid Arthritis Risk
Abstract Number: 841

Effect of Partial and Complete Proteinuria Recovery in Lupus Nephritis On Long Term Outcomes
Abstract Number: 1415

Effect of Renal Disease On Survival of Patients with Systemic Lupus Erythematosus: A Prospective Cohort Study of 694 Patients
Abstract Number: 1751

Effect of Repeated Infusions of Rituximab in Patients with Primary Sjögren’s Syndrome
Abstract Number: 1503

Effect of Thiol Antioxidants On the Profibrotic Phenotype of Scleroderma Dermal Fibroblasts
Abstract Number: 566

Effect of TNF Antagonists On Radiographic Progression in Psoriatic Arthritis: Systematic Review and Meta-Analysis of Randomized Controlled Trials
Abstract Number: 1243

Effect of Tocilizumab Treatment On Regional Left Ventricular Function, As Assessed by Cardiac Magnetic Resonance Imaging, in Rheumatoid Arthritis Patients without Cardiac Symptoms
Abstract Number: 1295

Effectiveness and Tolerability of Subcutaneous Tocilizumab in Rheumatoid Arthritis Patients Switched From Intravenous Tocilizumab: Results From the Extension Period of the Musashi Study
Abstract Number: 452

Effectiveness and Tolerance Infiltration Intraarticular Corticosteroid According to Dose
Abstract Number: 2056

Effectiveness of a Focused Educational Intervention in Improving the Supplementation of Vitamin D Deficiency and Insufficiency
Abstract Number: 297

Effectiveness of Intravenous Cyclophosphamide in Severe or Refractory Juvenile Dermatomyositis – A National Cohort Study: UK and Ireland
Abstract Number: 141

Effectiveness of Prophylaxis with Anti-Gout Medications On Risk of Gout Attacks
Abstract Number: 1156

Effectivity of Methotrexate in Therapy of Juvenile Idiopathic Enthesitis-Related Arthritis
Abstract Number: 2141

Effects of Cigarette Smoking On EARLY Arthritis (CONAART)
Abstract Number: 1323

Effects of Dose Escalation of Tocilizumab in Combination with Nonbiologic Disease-Modifying Antirheumatic Drugs: Sub-Analysis of a 24-Week Study in a United States Population
Abstract Number: 440

Effects of Fetal Microchimerisms On Disease Onset and Severity in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus
Abstract Number: 2408

Effects of Ground and Joint Reaction Force Exercise On Bone Mineral Density in Postmenopausal Women: A Meta-Analysis of Randomized Controlled Trials
Abstract Number: 2434

Effects of Interventions That Aim to Increase Exercise Adherence in People with Arthritis: A Best Evidence Synthesis
Abstract Number: 656

Effects of Nelfinavir On Anti-dsDna Antibody Binding and Pro-Inflammatory Cytokine Gene Expression
Abstract Number: 294

Effects of Obesity On Health-Related Quality of Life in Childhood-Onset Systemic Lupus Erythematosus
Abstract Number: 727

Effects of Odanacatib On BMD and Overall Safety in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated with Alendronate
Abstract Number: 1991

Effects of Odanacatib On the Distal Radius and Tibia in Postmenopausal Women: Improvements in Cortical Geometry and Estimated Bone Strength
Abstract Number: 2647

Effects of Pain Expectations On Neuromuscular Control of the Spine in Patients with Chronic Low Back Pain and Healthy Participants
Abstract Number: 2203

Effects of Reclassification Using the American College of Rheumatology Criteria On a Large cohort Sjögren’s Syndrome Patients
Abstract Number: 1075

Effects of siRNA Depletion of Interferon Regulatory Factor 5 On Pro-Inflammatory Cytokine Production and IgG Secretion by Primary Human Immune Cells in Response to TLR7/8 Stimulation
Abstract Number: 1238

Effects of Stress On Clinical Presentation of Patients with Early Rheumatoid Arthritis
Abstract Number: 1109

Effects of Strontium Ranelate On Hand Osteoarthritis – Analysis of Data From the Sekoia Trial
Abstract Number: 254

Effects of Strontium Ranelate On Knee Osteoarthritis Pain: A Responder Analysis
Abstract Number: 1340

Effects of Subcutaneous Abatacept or Adalimumab On Remission and Associated Changes in Physical Function and Radiographic Outcomes: One Year Results From the Ample (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
Abstract Number: 1290

Effects of Tofacitinib On Lipid Profiles and Cholesterol and Lipoprotein Kinetics in Patients with Rheumatoid Arthritis
Abstract Number: 1283

Effects of Tofacitinib On Patient-Reported Outcomes in Patients with Active Rheumatoid Arthritis Receiving Stable-Dose Methotrexate: Results of Two Phase 3 Studies
Abstract Number: 642

Effects of Treatment On the Expression of CCL2 and CXCL10 in Systemic Lupus Erythematosus Patients
Abstract Number: 476

Effects of Vitamin D Repletion and Maintenance Therapy On Clinical Indicators of Disease Activity in Rheumatoid Arthritis
Abstract Number: 539

Efficacy and Safety of Adalimumab for the Treatment of Peripheral Arthritis in Spondyloarthritis Patients without Ankylosing Spondylitis or Psoriatic Arthritis
Abstract Number: 750

Efficacy and Safety of Canakinumab in Adults with Colchicine Resistant Familial Mediterranean Fever
Abstract Number: 759

Efficacy and Safety of Canakinumab in Patients with Active Systemic Juvenile Idiopathic Arthritis and Fever: Results From Two Pivotal Phase 3 Trials
Abstract Number: 748

Efficacy and Safety of Canakinumab in Patients with Cryopyrin Associated Periodic Syndrome: Results From Meta-Analysis of 5 Studies
Abstract Number: 749

Efficacy and Safety of Canakinumab in Patients with TNF Receptor Associated Periodic Syndrome
Abstract Number: 1911

Efficacy and Safety of Canakinumab Vs Triamcinolone Acetonide in Patients with Gouty Arthritis Unable to Use Nonsteroidal Anti-Inflammatory Drugs and Colchicine, and On Stable Urate Lowering Therapy (ULT) or Unable to Use ULT
Abstract Number: 211

Efficacy and Safety of Disease Modifying Drugs, Biologic Therapies and Immunoglobulin in Patients with Polymyositis and Dermatomyositis: A Systematic Literature Review
Abstract Number: 471

Efficacy and Safety of Golimumab As Add-On Therapy to Disease-Modifying Antirheumatic Drugs
Abstract Number: 1883

Efficacy and Safety of Joint and Soft Tissue Injections; A Retrospective Study
Abstract Number: 1861

Efficacy and Safety of Pregabalin in Japanese Patients with Fibromyalgia: A Randomized, Double-Blind, Multicenter, Placebo-Controlled Phase III Trial and Open-Label Extension Study
Abstract Number: 2622

Efficacy and Safety of Rontalizumab (Anti-Interferon Alpha) in SLE Subjects with Restricted Immunosuppressant Use: Results of A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study
Abstract Number: 258

Efficacy and Safety of the Chinese Herbal Compound Hou-Lou-Xiao-Ling Dan in Patients with Osteoarthritis of the Knee: Results of a Phase II International Study
Abstract Number: 1597

Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data From a Phase 3 Trial
Abstract Number: 2459

Efficacy of Aspirin for the Prevention of the First Thrombo-Embolic Events in Patients with Antiphospholipid Antibodies: A Metanalysis of Literature Data
Abstract Number: 2241

Efficacy of Belimumab in Systemic Lupus Erythematosus Patients with High Baseline Disease Activity
Abstract Number: 2189

Efficacy of Belimumab On Non-Malignant Parotid Swelling and Systemic Manifestations of Sjögren’s Syndrome: Results of the Beliss Study
Abstract Number: 1142

Efficacy of Biologic Agents in Juvenile Idiopathic Arthritis: A Systematic Review Using Indirect Comparisons
Abstract Number: 142

Efficacy of Canakinumab Versus Triamcinolone Acetonide According to Multiple Gouty Arthritis-Related Health Outcomes Measures
Abstract Number: 1326

Efficacy of Different Biologic Agents for Improving Physical Function As Measured by the Health Assessment Questionnaire: A Meta-Analysis with Indirect Comparisons
Abstract Number: 263

Efficacy of Ketoprofen Vs Ibuprofen and Diclofenac: A Systematic Review of the Literature and Meta-Analysis
Abstract Number: 963

Efficacy of Long-Term Milnacipran Treatment in Patients Meeting Different Thresholds of Clinically Relevant Pain Relief: Subgroup Analysis of a Double-Blind, Placebo-Controlled Discontinuation Study
Abstract Number: 366

Efficacy of Methotrexate (MTX) According to Anti-Citrullinated Protein Antibody (ACPA) Status in an Early Inflammatory Arthritis Cohort
Abstract Number: 1591

Efficacy of Neoprene Wrist Supports for Patients with Rheumatoid Arthritis
Abstract Number: 2372

Efficacy of Quantitative Analysis of Brainstem Atrophy On Magnetic Resonance Imaging for Diagnosis of Chronic Progressive Neuro-Behçet’s Disease
Abstract Number: 220

Efficacy of Rituximab for the Treatment of Refractory Inflammatory Myopathies Associated with Anti-Histidyl-tRNA Synthetase Antibodies (the FORCE Jo1 Study)
Abstract Number: 2076

Efficacy of the Potent PI3K-δ,γ Inhibitor IPI-145 in Rat Adjuvant Arthritis
Abstract Number: 1212

Elevated Fecal Secretory Immunoglobulin A, Anti-Cyclic Citrullinated Peptide Antibodies, and Cytokine Levels in Rheumatoid Arthritis Patients
Abstract Number: 2336

Elevated Frequency of Synovial Interleukin-21⁺ CD4⁺ T Cells Co-Expressing Tumor Necrosis Factor-a in Rheumatoid Arthritis
Abstract Number: 2199

Elevated IgG4 Serum Levels Among Primary Sjogren’s Syndrome Patients: Do They Unmask Underlying IgG4-Related Disease?
Abstract Number: 1951

Elevated Level of Tumor Necrosis Factor-Like Weak Inducer of Apoptosis in Patients with Polymyositis or Dermatomyositis
Abstract Number: 619

Elevated Plasma Levels of CXCL2 and CXCL10 Have Distinct Predictive Value in Systemic Lupus Erythematosus
Abstract Number: 2656

Elevated Serum Follistatin-Like Protein 1 Suggests an Interleukin-1 Independent Pathway for Inflammation in Patients with Cryopyrin Associated Periodic Syndromes
Abstract Number: 1915

Elevated Serum Homocysteine Levels Were Related Not with Serum Uric Acid Levels but with Decreased Renal Function in Chronic Gouty Patients
Abstract Number: 2496

Elevated Serum Level of the Vascular Endothelial Growth Factor Is Highly Predictive for New Syndesmophytes Formation in Patients with Ankylosing Spondylitis
Abstract Number: 635

Elevated Transglutaminase Levels On Microparticles From Systemic Lupus Erythematosus Patients
Abstract Number: 850

Elevation of KL-6 At Early Disease Course Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease
Abstract Number: 1893

Eliciting Prescribing Choices of Anti-Tumour Necrosis Factor Therapy From Rheumatology Trainees
Abstract Number: 1865

Emotional Pain and Catastrophizing Influence Quality of Life in Fibromyalgia
Abstract Number: 863

Employment of a Needs Assessment Survey to Shape a Novel Web-Based Pediatric Rheumatology Curriculum for Primary Care Providers
Abstract Number: 1059

Endogenous Complement Factor H Plays an Important Role in Controlling Immune Complex-Induced Inflammatory Arthritis
Abstract Number: 699

Endothelial Dysfunction and Vascular Stiffness in Early Diffuse Systemic Sclerosis
Abstract Number: 623

Endothelial Microparticles As a Biomarker for Endothelial Dysfunction in Active Systemic Lupus Erythematosus
Abstract Number: 859

Endothelin-1 (ET-1) Induces Extracellular Matrix Protein Production by Human Temporal Artery Derived Myointimal Cells. A Mechanism Potentially Leading to Intimal Hyperplasia and Vascular Occlusion in Giant-Cell Arteritis
Abstract Number: 1472

Enhanced Liver Fibrosis Test: A Further Step Toward Depiction of Fibrotic Process in Very Early Diagnosis of Systemic Sclerosis
Abstract Number: 1644

Enhanced Pharmacovigilance Reporting of Malignancies in Children and Young Adults Taking Etanercept
Abstract Number: 2291

Enhanced Release of S100A9 and Hepatocyte Growth Factor by the Epidermis in Systemic Sclerosis
Abstract Number: 847

Enhanced ROCK Activation in Patients with Systemic Lupus Erythematosus
Abstract Number: 2310

Enhancement of CRACM1 Expression in Functionally Aberrant Naïve CD4⁺ T Cells in Active Rheumatoid Arthritis
Abstract Number: 2042

Enhancing Shared Decision-Making in Juvenile Idiopathic Arthritis
Abstract Number: 1072

Enzymatic Lipid Oxidation Contributes to the Maintenance of Self-Tolerance by Regulating Antigen Clearance and Dendritic Cell Function
Abstract Number: 556

Eos Imaging Could Replace Conventional Computed Radiography for Ankylosis Assessment in Axial Spondyloarthritis
Abstract Number: 14

EPAC1 Activation Is Required for NFkB Nuclear Translocation and Osteoclast Differentiation
Abstract Number: 1261

Epicardial Adipose Tissue Is Associated with Cardiometabolic Risk and the Metabolic Syndrome in Patients with Rheumatoid Arthritis
Abstract Number: 929

Epidemiology of the US National Burden of Pediatric Lupus Hospitalization From 2000-2009
Abstract Number: 313

Epigenetic Changes in Fibrosis and Myocyte Repair Genes May Contribute to Pathogenesis in Monozygotic Twins Discordant for Cardiac Manifestations of Neonatal Lupus
Abstract Number: 427

Epigenetic Features As Predictive Markers of Responsiveness to Epitope-Specific Therapy in Rheumatoid Arthritis
Abstract Number: 2284

Epigenetic Profiling in Monozygotic Twins Discordant for Systemic Lupus Erythematosus Reveals Prominent Hypomethylation of Interferon-Inducible Genes
Abstract Number: 2594

Epigenetic Signature of the Response to Anti-TNF in Juvenile Idiopathic Arthritis
Abstract Number: 419

Epigenome Analysis of Rheumatoid Arthritis Synovial Fibroblasts Revealed TBX-5 As a Novel Transcription Factor in Chemokine Regulation
Abstract Number: 1000

Epistatic Interaction Between BANK1 and BLK in Rheumatoid Arthritis: Results From a Large Trans-Ethnic Meta-Analysis
Abstract Number: 1628

Epistatic Interaction Between Solute Carrier 2A9 Genotype and Sugar-Sweetened Beverage Consumption in the Determination of Gout Risk
Abstract Number: 2252

Epratuzumab-Treated Systemic Lupus Erythematosus Patients Report Improvements in Health-Related Quality of Life: Final Results from an Open-Label Extension Study (SL0006)
Abstract Number: 1441

Epstein Barr Virus CD40 Functional Mimic Latent Membrane Protein-1 Drives Cellular Molecular Mimicry in the Presence of Epstein Barr Virus Nuclear Antigen-1 in a Novel Murine Model of Lupus-Like Disease
Abstract Number: 1411

Equivalence of Various Language Versions of Lupus Specific Patient Reported Outcomes Measure (LupusPRO)
Abstract Number: 1111

Erosive Evolution in Hand Osteoarthritis Is Associated with Incident Joint Tenderness Independent of MRI-Defined Bone Marrow Lesions and Synovitis
Abstract Number: 1389

Erythrocyte Sedimentation Rate Is a Predictor of Renal and Overall Systemic Lupus Erythematosus Disease Activity
Abstract Number: 2455

Establishment of Standardized International Units for IgG Anti-β₂glycoprotein Antibody Measurement
Abstract Number: 678

Estrogen Modulation of ZAS3 Is Mediated Through Estrogen Receptor α: An Underlying Mechanism of Gender-Bias in Systemic Lupus Erythematosus?
Abstract Number: 1451

Estrogen Receptor Alpha Deficiency Protects Against Cognitive Defects in Murine Lupus
Abstract Number: 1453

Estrogen Receptor Alpha Impacts Th17 Expansion in Murine Lupus
Abstract Number: 664

Estrogen Upregulates Interleukin-21 Production of Clusters of Differentiation 4 Positive T Lymphocytes in Patients with Systemic Lupus Erythematosus
Abstract Number: 480

Etanercept Induces A Significant Decrease of Oxidative Stress and Osteoprotegerin Compared with Sdmard in Patients with Rheumatoid Arthritis
Abstract Number: 1420

Ethnicity and B Cell Depletion Therapy in Systemic Lupus Erythematosus
Abstract Number: 188

Etiology of Uveitis: A Hospital-Based Study in a Referral Centre
Abstract Number: 163

Evaluating Allopurinol Therapy and Serum Uric Acid Levels in Medicare Beneficiaries with Gout
Abstract Number: 138

Evaluating Appropriate Use of Prophylactic Colchicine and Urate Lowering Therapy in Gout
Abstract Number: 278

Evaluating Cardiovascular Risk Factors of Impaired Glucose Tolerance, Diabetes Mellitus, and Metabolic Syndrome in a Primarily Latino Population with Pediatric Rheumatic Diseases Associated with Vasculitis
Abstract Number: 1832

Evaluating the Cost-Effectiveness of Personalized Treatment with Adalimumab Using Serum Drug Levels in Rheumatoid Arthritis Patients
Abstract Number: 1928

Evaluating the Therapeutic Effects of B Cell Depletion Therapy with Rituximab in a Longitudinal Cohort of Mixed Connective Tissue Disease Patients
Abstract Number: 1886

Evaluation of a New Educational Tool: A Resident’s Guide to Pediatric Rheumatology
Abstract Number: 179

Evaluation of Anakinra Therapy in Seven Adults After Suboptimal Response to Etanercept Therapy for Tumor Necrosis Factor Receptor-Associated Periodic Fever Syndrome
Abstract Number: 1047

Evaluation of Ankle Swelling Due to Löfgren´s Syndrome: A Pilot Study Using B –mode and Power Doppler Ultrasonography
Abstract Number: 320

Evaluation of Anti-Citrullinated Type II Collagen and Anti-Citrullinated Vimentin Antibodies in Patients with Juvenile Idiopathic Arthritis
Abstract Number: 2362

Evaluation of Disease Activity Using FDG PET-CT in Patients with Large Vessel Vasculitis
Abstract Number: 1106

Evaluation of Foot Posture and Plantar Pressure Changes in Knee Osteoarthritis: Preliminary Report
Abstract Number: 1284

Evaluation of Influenza and Pneumococcal Vaccine Responses in Patients with Rheumatoid Arthritis Receiving Tofacitinib
Abstract Number: 120

Evaluation of Joint Involvement in Patients Suffering From Early Polymyalgia Rheumatica Using High Resolution Ultrasound
Abstract Number: 1266

Evaluation of Metabolic Syndrome in 97 Patients with Rheumatoid Arthritis
Abstract Number: 1362

Evaluation of Spondyloarthritis activity by the Patients and the Physicians: ASDAS, Basdai, PASS and Flare
Abstract Number: 1926

Evaluation of Strategies to Taper Anti-TNF Drugs in Patients with Inflammatory Rheumatic Disease (Rheumatoid Arthritis, Ankyloing Spondylitis, Psoriatic Arthritis, Adult-age Juvenile Idiopatic Arthritis) in Long-Term Remission
Abstract Number: 1

Evaluation of Synovial Inflammation Assessed by Macroscopic and Histological Criteria in Patients with Knee Osteoarthritis
Abstract Number: 1831

Evaluation of the Cost-Effectiveness of Rheumatoid Arthritis Treatment with Biologic Agents Using the IORRA Cohort Database
Abstract Number: 2378

Evaluation of the EULAR/ACR 2012 Classification Criteria for Polymyalgia Rheumatica: Comparison of the New Algorithms with and without Ultrasound to the Formerly Used Criteria
Abstract Number: 2217

Even After Pretreatment with up to Three Biologics, Anti-TNFs Shows Effectiveness in Active Psoriatic Arthritis Patients
Abstract Number: 867

Events That Trigger the Onset of the Fibromyalgia Syndrome (FMS)
Abstract Number: 1789

Evidence for an Additive Effect of Tumor Necrosis Factor Alpha and Hypoxia to Promote Bone Destruction in Arthritis
Abstract Number: 1615

Evidence for Distinct Roles of Environmental and Genetic Factors in the Emergence of Anti Citrullinated-Protein Antibodies Positive Rheumatoid Arthritis-an Epidemiological Investigation in Twins
Abstract Number: 2164

Evidence for NF-Kb Intracellular Signaling Involvement Following CTLA4-Ig (Abatacept) Treatment of Human Macrophages
Abstract Number: 594

Evidence of Human Leucozyte Antigen-B27 in Healthy Individuals and Patients with Uveitis Is a Risk Factor for Alterations in Bone Metabolism
Abstract Number: 997

Evidence of Novel Genetic Predictors of Methotrexate Efficacy in Rheumatoid Arthritis
Abstract Number: 2450

Evoked Pain Brain Response Is Associated with Reduced μ-Opioid Receptor Binding in Fibromyalgia
Abstract Number: 596

Evolution of Atherosclerosis in Psoriatic Arthritis: Is the Former an Independent Inflammatory Process?
Abstract Number: 1688

Evolution of Preclinical Autoimmunity in Individuals At Risk for Development of Rheumatoid Arthritis
Abstract Number: 1787

Evolution of the Cytokine and Chemokine Profile in Patients Receiving Oral Daily Vitamin D: Results From a Randomized Controlled Trial
Abstract Number: 2341

Exacerbation of Collagen-Induced Arthritis by an Anti-CD3 Antibody Targeting Aminoterminal-Deficient CD3ε
Abstract Number: 2694

Examination of a Multidimensional Model of Disability and Role Functioning in Patients with Rheumatoid Arthritis
Abstract Number: 581

Examining a Role for Th17 Regulation and Toll-Like Receptor Signaling in Psoriatic Arthritis
Abstract Number: 241

Excess Body Weight and 4-Year Function Outcomes: Comparison of African-Americans and Caucasians in the Osteoarthritis Initiative
Abstract Number: 624

Excess Health Care Utilization Prior to Diagnosis of Systemic Lupus Erythematosus in England
Abstract Number: 706

Excess Mortality From Atherosclerotic Cardiovascular Disease in Systemic Sclerosis Compared to Lupus and Rheumatoid Arthritis
Abstract Number: 2399

Exercise On Prescription: Barriers to Participation in Community Based Exercise Programmes
Abstract Number: 221

Expanding the Clinical and Serological Spectrum of MDA5-Associated Dermatomyositis
Abstract Number: 1772

Expansion of Autoreactive Unresponsive CD21^-/Low B Cells in Sjögren’s Syndrome Associated Lymphoproliferation
Abstract Number: 1462

Expert Consensus for Performing Right Heart Catheterization in Suspicion of Pulmonary Arterial Hypertension Associated with Systemic Sclerosis: A Delphi Consensus Study with Cluster Analysis From the Eposs Group
Abstract Number: 2605

Exploration of Possible Preliminary Descriptions of Remission Based On RAPID3, without Laboratory Tests or Formal Joints Counts but with Careful Joint Examinations, in the Etude Et Suivi Des Polyarthrites Indifférenciées Récentes (ESPOIR) Cohort of Early Rheumatoid Arthritis Patients
Abstract Number: 815

Exploratory Analysis of Radiographic Change in Patients Treated with Intensive Urate-Lowering Therapy
Abstract Number: 1722

Exploring How Patients with Rheumatoid Arthritis Use a Methotrexate Decision Aid for Making Treatment Choices
Abstract Number: 2635

Exploring the Influence of Patient Perceptions On Medication Escalation in Daily Practice
Abstract Number: 1851

Exploring the Relationship of Anti-Tumor Necrosis Factor Drugs and Methicillin Resistant Staphylococcus Aureus Nasal Colonization in Patients with Rheumatologic Conditions and Psoriasis
Abstract Number: 2506

Expression of Helios Facilitates Distinction Between FoxP3⁺ Treg and FoxP3⁺ Activated T Conventional Cells in Patients with Systemic Lupus Erythematosus
Abstract Number: 1944

Expression of Human Leukocyte Antigen-G in Polymyositis or Dermatomyositis
Abstract Number: 507

Expression of Micrornas (miRNAs) Predicted to Target Ro/SSA and La/SSB Autoantigens in Sjögren’s Syndrome (SS)
Abstract Number: 1759

Expression of Surface APRIL and Its Receptor, TACI, Is Upregulated On B Cells From Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients
Abstract Number: 688

Expression of the Mer Receptor Tyrosine Kinase On Peripheral Blood Mononuclear Cells From Systemic Lupus Erythematosus Patients
Abstract Number: 2454

Expression of TLR5 Strongly Correlates with Levels of TNF-a and DAS28 in RA Monocytes and Ligation of TLR5 Induces Angiogenesis in RA
Abstract Number: 698

External Validation of a Two-Year Mortality Risk Prediction Rule in Early Diffuse Systemic Sclerosis Patients
Abstract Number: 1066

Extrathymic Autoimmune Regulator (AIRE) Expression in Rheumatoid Arthritis